PROG Stock Price, News & Analysis

prog NASDAQ

Company Description

Welcome to the overview page for PROG (prog), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—

0.00%

0.00

Last updated:

-

Performance 1 year

$162.9M

184.2M

Shares outstanding

Latest News

May 5, 2022

5.95%

Progenity Announces Successful Transfer of Liquid Biopsy Technologies

May 3, 2022

1.88%

Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.

conferences earnings

April 25, 2022

3.26%

Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms

management

April 12, 2022

5.50%

Progenity to Become Biora Therapeutics as it Completes Transformation

April 6, 2022

3.42%

Progenity Announces Two Poster Presentations at Controlled Release Society 2022

March 28, 2022

22.98%

Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

earnings

SEC Filings

No SEC filings available for PROG.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the market cap of PROG (prog)?

The market cap of PROG (prog) is approximately 162.9M. Learn more about what market capitalization means.